Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab.
Infectious causes of multiple sclerosis.
Energy Cost of Walking and Its Association With Gait Parameters, Daily Activity, and Fatigue in Persons With Mild Multiple Sclerosis.
Sleep Disorders and Multiple Sclerosis: A Clinical and Polysomnography Study.
Food and Drug Administration briefing document for ofatumumab
Low-contrast visual tests reveal better alemtuzumab efficacy
Multiple sclerosis: Spinal cord grey matter loss correlates with disability in MS.
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.
Acute disseminated encephalomyelitis in children: a single institution experience of 28 patients.
Glossopharyngeal neuralgia secondary to vascular compression in a patient with multiple sclerosis: a case report.
Receptos begins enrollment of Phase 3 trial of RPC1063 in relapsing multiple sclerosis
Apitope Announces Completion of Enrolment in Phase IIA Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
Exercise and quality of life in women with multiple sclerosis.
Minocycline treatment for rheumatoid arthritis: an open dose finding study.
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy.
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Moving towards the pan-European unification of Multiple Sclerosis Nurses: a consensus paper.
Plasma Exchange in a Patient with Tumefactive, Corticosteroid-Resistant Multiple Sclerosis.
Frequent but nonspecific venous narrowing in paediatric multiple sclerosis.
1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
Pages
« first
‹ previous
…
155
156
157
158
159
160
161
162
163
…
next ›
last »